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Background: Many hypothesis-driven genetic studies require the ability to comprehensively and efficiently target
specific regions of the genome to detect sequence variations. Often, sample availability is limited requiring the use
of whole genome amplification (WGA). We evaluated a high-throughput microdroplet-based PCR approach in
combination with next generation sequencing (NGS) to target 384 discrete exons from 373 genes involved in
cancer. In our evaluation, we compared the performance of six non-amplified gDNA samples from two HapMap
family trios. Three of these samples were also preamplified by WGA and evaluated. We tested sample pooling or
multiplexing strategies at different stages of the tested targeted NGS (T-NGS) workflow.
Results: The results demonstrated comparable sequence performance between non-amplified and preamplified
samples and between different indexing strategies [sequence specificity of 66.0% ± 3.4%, uniformity (coverage at
0.2× of the mean) of 85.6% ± 0.6%]. The average genotype concordance maintained across all the samples was
99.5% ± 0.4%, regardless of sample type or pooling strategy. We did not detect any errors in the Mendelian patterns
of inheritance of genotypes between the parents and offspring within each trio. We also demonstrated the ability
to detect minor allele frequencies within the pooled samples that conform to predicted models.
Conclusion: Our described PCR-based sample multiplex approach and the ability to use WGA material for NGS may
enable researchers to perform deep resequencing studies and explore variants at very low frequencies and cost.
Keywords: High-throughput targeted next-generation resequencing, Microdroplet-based multiplex PCR, Sample
pooling or multiplexing, Whole-genome amplified DNA samples, Cost reductionBackground
Researchers have undertaken large genome-wide associ-
ation studies (GWAS), linkage analyses and candidate
gene studies to elucidate underlying variations to better
understand complex biological paradigms. These individual
genotyping approaches typically explain up to 25% [1] of
the heritable risk of common, complex polygenic disease
and usually miss potentially relevant rare alleles [2].
Nevertheless, GWAS have identified many regions that
require additional studies to further identify the causative
variants within them. Recently, the advent of next-
generation sequencing (NGS) technologies [3] has enabled* Correspondence: a.franke@mucosa.de
1Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel,
Germany
Full list of author information is available at the end of the article
© 2012 ElSharawy et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orresearchers to catalogue and estimate the contribution of
many different types of medically important genetic variants
(common and rare SNPs, insertions and deletions, known
and novel variants) that have the potential to explain new
aspects of the not yet identified heritability [4,5].
NGS technologies clearly have a higher throughput
than traditional Sanger sequencing at a significantly
lower per base cost, enabling the reading of whole gen-
ome(s) in a short period of time [6,7]. Nevertheless,
whole genome sequencing is not time or cost effective if
the researcher is only interested in a small percentage of
the genome in a large number of samples. Therefore,
numerous targeted NGS (T-NGS) approaches have been
developed to allow selecting and enriching intended
regions from a DNA sample before entering into theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of only genomic regions of interest, a T-NGS approach
can be more cost-effective and result in considerably less
weighty data to handle and analyze [8]. Several standar-
dized T-NGS approaches exist that allow whole exome
sequencing for Mendelian disorders [9]. Additionally,
special-purpose and customized T-NGS approaches
allow gene loci of interest to be analyzed that are not
sufficiently addressed by exome approaches/kits.
The targeted enrichment methods described so far
fall mainly into three categories: hybridization capture,
PCR/amplification-based and selective circularization
approaches. These methods differ in several aspects
such as the use of solution versus solid-phase hybridization,
probe design, cost per sample and workflows with implica-
tions for automation. In fact, each method has its own
advantages and disadvantages [7,8,10,11]. In choosing a
target-enrichment approach there can also be many points
to consider and balance, such as genomic complexity and
nature of the region of interest, study specific needs and
objectives, desired fold enrichment, specificity as well as
available budget.
When ‘indexing’ strategies are applicable during the
process [12-14], a multiplex T-NGS approach can enable
the researcher to efficiently leverage the massive
throughputs offered by NGS platforms and process more
samples in parallel. Molecular barcoding protocols can
be used to index different samples together within the
same sequencing run. In doing so, the sequencing costs
can be amortized across each sample resulting in lower
per sample sequencing costs and the ability to quickly
process enough samples to achieve the necessary statis-
tical power in an experimental design.
Genomic DNA (gDNA) is often a limiting resource
and whole genome amplified (WGA) gDNA is usually
prepared/used within many human disease studies to
preserve the original precious resources. However, the
effect of WGA gDNA on variant discovery from T-NGS
data is unclear and needs careful evaluation [8]. To
process WGA samples we need to use a target-enrichment
method that shows a high specificity in order to tackle, to
some extent, bias issues that can be introduced during
WGA preparation. The recent benchmark experience
with the leading target-enrichment technologies [8,10]
concluded that both PCR- and circularization-based
methods are superior to hybrid capture methods with
respect to achieved specific and uniform sequence
coverage, albeit they are not able to target large regions
in a single experiment, which is in contrast an advantage
of hybrid capture approaches.
To this end, the objective of this work was to (1) evalu-
ate the accuracy of variation discovery within T-NGS data
obtained from matched non-amplified and preamplified
WGA HapMap gDNA samples, and (2) test the effect ofsample multiplexing for cost- and time-saving reasons, at
different stages of the sequencing workflow, on key
enrichment metrics. We targeted 384 discrete exons
involved in cancer [15] using a combined T-NGS
workflow of a microdroplet-based PCR sample enrich-
ment pipeline (RainDance Technologies, Inc. USA) and a
NGS technology platform (SOLiD, Life Technologies,
USA). The results suggest that using WGA as a starting
material and pooling PCR-based enriched samples before
sequencing don’t substantially impact on the performance
of the analyses.
Methods
The here established workflow and study design are
shown in Figure 1.
Samples tested
In this study we evaluated six HapMap gDNA samples
(Coriell Repositories, USA), members of two family trios
(IDs 1350 and 1420). We tested samples IDs NA11829,
NA11830, and NA10856 of family ID 1350, and
NA12003, NA12004, and NA10838 of family ID 1420.
Whole-genome amplification of the same three gDNA
samples of family ID 1420 was prepared following standard
protocol of GenomiPhi V2 Amp Kit 500 RXS (Amersham
Biosciences; GE Healthcare Europe GmbH). In each WGA
reaction, one μl gDNA (concentration 10 ng/μl) served as a
start material. A typical WGA gDNA yield of 4–7 μg gDNA
(~ 250 ng/μl) with average product length of >10 kb was
achieved. After verifying the quality of the DNA/WGA
samples, the enrichment of the intended target regions of
all nine samples, six non-amplified gDNA and three
matched WGA gDNA, were undertaken using droplet-
based multiplex PCR (RainDance; USA) as described
below.
Targeted genomic sequences and primer panel design
The RainDance Technologies “384 Member Primer
Panel” targets 384 Consensus CDS exons from 373
different genes thought to contain somatic mutations
involved with cancer [15]. Amplicons were designed as
described by Sjoblom et. al. The amplicons contained in
the RainDance “384 Member Primer Panel” represent
172,053 amplicon bases (Additional file 1: Table S2).
Amplicons were selected to represent several different
design parameters that include: amplicon length (300 to
600 bases), amplicon GC content (30 – 60%) and Primer
Tm (56 - 60°C). The RainDance “384 Member Primer
Panel” contains 384 unique primer droplets, one for
each amplicon in the panel. The forward and reverse
primers for each amplicon are synthesized and combined
into a single primer aliquot in the well of a standard
microtiter plate. Each primer droplet contains an equal
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Figure 1 Experimental Workflow and Study Design. This Figure shows the tested samples (individual, pooled, non-amplified gDNA, and
matched WGA) using the established T-NGS workflow (for more details see Additional file 3: Table S1). Each enriched individual sample was
barcoded and sequenced under the following conditions: 1) one sample per octet, 3) samples were pooled after SOLiD library construction, pre-
emulsion PCR (emPCR), and 3) samples were pooled post-emPCR. To assess the reproducibility of the established T-NGS method, equimolar
amounts of the enriched six HapMap samples were also pooled before SOLiD library construction and tested in duplicate (Libraries ID 768_1L
and 768_2L are technical replicates).
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ate an emulsion containing many primer droplets that are
identical to each other, each containing a single primer
pair. The primer droplets are 25 μm in diameter with a
volume of eight pL per droplet. Each primer droplet is
evaluated for its size and morphology to ensure each pri-
mer is represented at the same concentration. An auto-
mated counting process quantifies the number of primer
droplets generated from each primer aliquot. The different
primer droplets are then mixed together to ensure that
each primer panel has the same number of each unique
primer droplet.
Genomic DNA fragmentation
Genomic DNA samples were fragmented using a nebuliza-
tion kit (Invitrogen, K7025-05) following the manufacturer’s
recommended protocol: 2.0 μg of gDNA was re-suspended
in 750 μL Shearing Buffer (TE, pH 8.0 (Fisher, 50843207)
containing 10% glycerol (Fisher, AC15892)) and wasnebulized at 6–10 lb per square inch (psi) for 90 s to pro-
duce 2–4 kb DNA fragments. Fragmentation of the gDNA
to 2–4 kb produces the optimal template size for the
amplicons size distribution represented in the RainDance
“384 Member Primer Library”. Sheared gDNA was preci-
pitated by adding 80 μL 3 M sodium acetate, pH 5.2
(Fisher, 50843081), 4 μL 20 mg/ml Mussel Glycogen
(Fisher, NC9329100) and 700 μL 100% isopropanol
(Fisher, AC14932) mixed and stored overnight at −20°C.
The samples were then centrifuged at the maximum speed
for 15 min at 4°C. The supernatant was removed, 500 μL
of cold 80% ethanol (Fisher, 5739852) wash buffer was
added and the DNA pellet was spun down by centrifuga-
tion at the maximum speed for 5 min at 4°C. The pellet
was air dried and re-suspended in 10 μL 10 mM Tris–
HCl, pH 8.0 (Sigma, T2694). Fragmented genomic DNA
was run on a 0.8% agarose gel to confirm that the genomic
DNA was in the correct size range (2–4 kb), data not
shown.
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In order to prepare the gDNA Template Mix, 1.5 μg of
the purified fragmented gDNA was added to 4.7 μL 10×
High-Fidelity Buffer (Invitrogen, 11304–029), 1.26 μL of
MgSO4 (Invitrogen, 11304–029), 1.6 μL 10 mM dNTP
(New England Biolabs, NO447S/L), 3.6 μL Betaine
(Sigma, B2629-50 G), 3.6 μL of RDT Droplet Stabilizer
(RainDance Technologies, 30–00826), 1.8 μL dimethyl
sulfoxide (Sigma, D8418-50 ml) and 0.7 μL 5 units/μL of
Platinum High-Fidelity Taq (Invitrogen, 11304–029) the
samples was brought to a final volume of 25 μL with
Nuclease Free Water, Teknova (Fisher, 50843418).
Merge genomic DNA template Mix and primer panel
droplets: RDT 1000 instrument
PCR droplets were generated on the RDT 1000 (RainDance
Technologies, Inc. USA) one droplet at a time using the
manufacturer’s recommended protocol. All of the resulting
PCR droplets were automatically dispensed as an emulsion
into a single PCR tube and transferred to a standard
thermal cycler for PCR amplification. Each sample gener-
ated an emulsion containing more than 1,000,000 droplets
in which each droplet contained a single-plex polymerase
chain reaction (PCR) that targeted one of the 384 targets
defined by the RainDance Technologies “384 Member
Primer Panel”. Each amplicon was represented by multiple
unique PCR droplets (Additional file 2: Figure S1).
PCR amplification
Samples were cycled in a Bio-Rad PTC-225 thermal
cycler with the following profile: 94°C for 2 min;
55 cycles at 94°C for 15 s, 58°C for 15 s, 68°C for 30 s;
68°C for 10 min and hold at 4°C.
Breaking emulsion
After PCR Amplification the emulsion of PCR droplets
were broken, to release each individual amplicon from
the PCR droplets, using the manufacturer’s recommended
protocol.
PCR product clean Up
Each sample was purified over a MinElute column (Qiagen,
28004) following the manufactures recommended protocol.
The sample was eluted off the column with 11 μL of the
Qiagen Elution Buffer. The purified amplicon DNA was
then run on an Agilent Bioanalyzer to confirm that the
amplicon profile (Additional file 2: Figure S2 A) matches
the predicted histogram distribution (Additional file 2:
Figure S2 B).
SOLiD sequencing library construction and sample
indexing
The sequencing libraries were constructed according to
the Standard Fragment Library preparation of the SOLiD3.0 system protocols (Applied Biosystems, USA). Six
individual sequencing libraries were prepared using the
enriched non-amplified gDNA PCR products and
indexed with barcodes 1 to 6 (Libraries IDs 759L-BC1,
760L-BC2, 761L-BC3, 762L-BC4, 763L-BC5 and 764L-
BC6, respectively). Three other libraries were prepared
using the enriched WGA gDNA products and indexed with
barcodes 9, 10 and 11 (Library IDs 765L-BC9, 766L-BC10
and 767L-BC11, respectively) (Figure 1 and Additional file
3: Table S1). In parallel, to test the performance of sample
pooling before library preparation, equimolar portions of
each of the six non-amplified gDNA enriched products
(based on final concentration of each sample) were pooled
together in duplicates and library IDs 768_1L and 768_2L
were prepared. In total, 11 Standard Fragment Libraries
were prepared (six individual gDNAs, three individual
WGAs, and two pools, which comprised two duplicate
pools of the six non-amplified gDNA enriched products)
(details in Additional file 3: Table S1). For each library
0.5-1.0 μg enriched gDNA/WGA/pool was used.
Purification of the SOLiD libraries
After library preparation, sizing, quantification and quality
control of the prepared SOLiD libraries were performed on
Agilent Bioanalyzer 2100 (Agilent Technologies, Waldbronn,
Germany). A typical electropherogram obtained (Additional
file 2: Figure S3 A) showed a primer-dimer peak between
60 and 70 bp (~68 bp). These primer-dimers, and other
unincorporated dNTPs, primers, salts and other con-
taminants, were removed and PCR amplicons >100 bp
were recovered according to the standard procedure of
Agencourt AMPure Kit (Beckman Coulter Genomics).
Removal of the primer-dimers from the SOLiD library
construction and sample indexing step was necessary to
reduce the carryover of these products into the library.
After the purification step, sizing and quantification of
all the generated libraries were measured again on the
Agilent 2100 Bioanalyzer (Additional file 2: Figure S3 B)
shows a typical electropherogram after purification).
Pooling strategies of indexed samples
We evaluated here the performance of sample indexing
and pooling before and after the emPCR step. After
library purification, emPCR was carried out for three
different scenarios (summarized in Figure 1): A) Nine
individual emPCRs were carried out for the non-
amplified gDNA’s (six reactions; emulsion IDs 759em,
760em, 761em, 762em, 763em and 764em) and the
WGA gDNA’s (three reactions; emulsion IDs 765em,
766em and 767em). B) Two emPCR reactions were carried
out from the two pooled samples before library
construction: emulsion IDs 768_1em and 768_2em. C)
Equimolar portions of five of the non-amplified gDNA
libraries (IDs 759L, 760L, 761L, 762L and 764L) were
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770em (pB)). Library ID 763L with BC 5 was not pooled
with the afore-mentioned five gDNA libraries due to its
low concentration, which was only appropriate for one
emPCR of the individual library ID 763em. Finally, after
performing all the afore-mentioned emPCR reactions, a
single pool of equimolar amounts of the obtained individual
emPCR products from non-amplified gDNA emulsion IDs
759em, 760em, 761em, 762em, 763em and764em was
generated and processed in parallel (emulsion ID 792em
(pA)). Therefore, a total of 13 emPCR reactions were per-
formed for all the tested comparisons (details in Additional
file 3: Table S1 and Additional file 2: Figure S1).
NGS using SOLiD 3.0 system platform
The sequencing was carried out on the SOLiD 3.0 system
platform (Applied Biosystems/Life Technologies, MA,
USA) using Standard Fragment Library protocol and
lengths of 50 bp according to the manufacturer’s instruc-
tions (Applied Biosystems, MA, USA). The principle steps
of the SOLiD sequencing protocol are well covered
[11,16-18]. Here each enriched product (single or pooled
libraries) was run on a single well/spot of an octant slide.
A total of 13 wells/spots were used (759seq, 760seq,
761seq, 762seq, 763seq, 764seq, 765seq, 766seq, 767seq,
768_1seq, 768_2seq, 770seq and 792seq), i.e. one complete
octant slide (8/8) and five spots (two-thirds) of a second
octant slide (5/8), for these experiments to sequence the
13 different sequencing samples (listed in Additional file 3:
Table S1 and Additional file 2: Figure S1). The SOLiD
platform interrogates each base by two separate probe
hybridizations (i.e. two color calls), which has the advan-
tage of improved base calling accuracy (invalid color call
sequences point to sequencing errors). The color space
reads are translated into (base space) fasta code during
alignment to a reference genome, which is performed off
the machine, on a high performance computer cluster.
Mapping the SOLiD sequencing data
SOLiD sequencing reads (50 bp) were aligned to the human
genome (hg18/NCBI36) using the CLCbio Genomics
Workbench (v 3.0) [19] with a custom RainDance Work-
flow plug-in, and in-house Perl scripts. Before assembly, the
reference genome was annotated with the 384 amplicon
targets, consisting of 382 discontiguous regions, using a gff
file (Additional file 1: Table S2). Primer locations of non-
overlapping amplicon targets were omitted from analysis
as SNP detection is not possible under the primer as the
PCR will generate amplicon product for these regions
from the primer and not the gDNA. Default settings for
reference assembly (Additional file 3: Table S3) were used.
Non-unique reads were mapped randomly to possible
placements. All aligned sequence reads were exported in
SAM [20] format.Sequence variant identification
Single nucleotide sequence variants were identified using
the CLC bio Genomics Workbench (v 3.0), using default
settings with the following exceptions: minimum allele
frequency was set to 10%, minimum coverage was set to 5,
maximum coverage was set to 15,000. Only SNPs that were
located in amplicon target regions, excluding primer
locations, were analyzed. Nucleotide coverage of known
SNP positions in the target regions were extracted using a
Perl wrapper in combination with Samtools 0.1.7 [20].
Samtools pileup files were combined with a Perl script.
Nucleotide sequence data reported are available in the
GenBank databases (the Sequence Read Archive (SRA))
under the study accession number ERP000999 [21]).
Data analysis
SNP concordance was determined by comparing
HapMap genotype data (HapMap Public Release #27,
merged II + III) to SNPs found using the CLC bio
Genomics Workbench. Caucasian (CEU) HapMap
SNPs from NA12003, NA12004, NA10838, NA11829,
NA11830, and NA10856 were downloaded from [22].
SNPs detected from the SOLiD sequencing data were
also compared to SNPs from dbSNP, Build 130. A
Perl script was written to extract all known SNPs
from the six HapMap samples.
SNPs were considered heterozygous if non-reference
allele frequency was 10-90%. SNPs were considered
homozygous if non-reference allele frequency was equal
to or greater than 90%. For a SNP to be considered
detected, the SNP had to have at least five reads per
allele. Therefore a heterozygous SNP had to have at
least 10 counts per position to be considered “detected”.
Only detected SNPs were used for concordance
calculations.
Results
The experimental workflow and investigated samples are
summarized in Figure 1. Several experimental alterna-
tives were performed to investigate the effect of using
WGA gDNA material and different pooling strategies on
the performance of selective recover of genomic sub-
regions of interest and on variant detection.
Sample throughput, sequence capacity and enrichment
metrics
Genomic alignment and SNP detection were carried out as
described in Methods. On average, 66% of the sequencing
reads that aligned to the human genome (that were 30-40%
of total raw reads), mapped to the target regions. This on-
target percentage, or specificity, appeared unaffected by the
pooling strategy used. However, a slight decrease in speci-
ficity was observed in the WGA samples. For example,
specificity of sample NA12003, NA12004, and NA10838
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gDNA to 63.2%, 64.4%, and 57.8%, respectively, for the
WGA samples.
The C1 coverage was high (>99%) across all of the
non-pooled samples indicating a success of each primer
pair to produce an amplicon. All of the expected amplicons
in this panel (383/383) produced a PCR product. Ampli-
cons with low coverage might result from the inability
for the sequencing chemistry to sequence through the
sequence context of the amplicon.
Although coverage at 20× (C20) varied, it correlated to
mean base coverage as expected. However, normalized
base coverage (C0.2× of the mean) was consistent
throughout all the samples (85.6% ± 0.6%), suggesting
that the utilized enrichment process is robust and repro-
ducible. For samples with mean base coverage of at least
200 reads per base, C20 was at least 90%. For all samples
that had a mean target base coverage of 200 reads per
base, the percentage of bases that were covered at least
once (C1) was greater than 98%. Also, C1 increased to
99.4-99.7% when mean base coverage was greater than
1000×. In addition, the results not only showed adequate
average coverage and enrichment folds for reliable SNP
discovery, but also adequate uniform coverage of the
barcoded and pooled samples before and after emPCR
(Additional file 2: Figure S4). A low number of reads of
the samples indexed with BC4 was observed (gDNA-pB
770- BC4 and gDNA-pB 792- BC4; Table 1), compared to
all other indexed samples with other barcodes. Consequent
lower coverage (Table 1) and SNP detection rates (Table 2)
were also observed – while the concordance rates were not
similarly affected. The substantial underrepresentation of
samples indexed with BC4 has also been revealed in other
in-house multiplex experiment including BC4 on human
gDNA samples using different sample enrichment
technologies (see Discussion).
Altogether, the results shown in Table 1 demonstrate
good performance on both non-amplified gDNA and
WGA gDNA samples with no substantial difference in
the sequence performance among the samples and reveal
specificity of 66.0% ± 3.4% and uniformity (Coverage at
0.2× of the mean) of 85.6% ± 0.6%.
As a higher coverage depth is a pre-requisite for
somatic and rare variant identification in particular,
the samples were re-analyzed to calculate the coverage
beyond 20-fold (C20) in our experimental design
(Additional file 3: Table S4). The C30, C50 and C100
for the individual samples, which were each sequenced
in a separate octet (759L, 760L, 761L, 762L, 763L and
764L), maintained high levels of average coverage
across the target region (C30 = 97.76%, C50 = 97.24%
and C100 = 96.08%). The individually barcoded sam-
ples expectedly showed lower coverage at C30, C50 and
C100 (average coverage C30 = 94.31%, C50 = 91.54% andC100 = 83.87%). These results suggest that this T-NGS
methodology may be applied for the analysis of genetic
variations in cancer genes.
Variant detection and concordance - SNP concordance
with HapMap genotypes
To determine the concordance of the variant detection,
the generated sequences per HapMap sample were com-
pared to their reference genotypes and across the different
sample treatments (non-amplified gDNA, WGA gDNA,
single and pooled). Summary concordance data is shown
in Table 2. In total 333 SNPs were compared and false
negative detection rates were estimated (Table 2). In
general, the results shown in Table 2 indicate low false
negatives (0.0 to 3.3%). Individually sequenced samples
showed a modestly lower false negative detection rate
(0.3% and 0.2%, for non-amplified gDNA and WGA,
respectively) than that of the corresponding pooled gDNA
and WGA gNDA paired samples (1.3 to 1.9%). The SNP
detection rate correlated with the mean base coverage,
and was unaffected by the pooling strategy. Importantly,
the WGA gDNA samples showed nearly similar concord-
ance rate to that of the non-amplified gDNA samples
(Table 2). Overall, concordance averaged 99.5% and
generally remained unchanged, regardless of the applied
pooling strategy.
Efficiency and detection SNP rates of Non-barcoded and
pooled samples
The sequencing results of the two technical replicates
(samples 768_1L and 768_2L) were used to analyze dif-
ferent enrichment measures, variant detection rates, and
the reproducibility of the method. Samples 768_1L and
768_2L were pooled from sample ID’s 1, 2, 3, 4, 5 and 6
and represented HapMap samples NA12003, NA12004,
NA10838, NA11829, NA11830, and NA10856, respectively
(Figure 1). Since genotyping data from NA12004 was
limited for all positions that were considered, genotypes
were inferred from the non-barcoded samples and used
for comparison. Because we were inferring genotypes from
the sequencing data, it allowed us to generate a larger SNP
set which also included non-HapMap and non-dbSNP
(build 130) SNPs. These non-dbSNP SNPs could represent
valid, potential novel SNPs.
This strategy to infer SNPs with confidence stemmed
from the knowledge that we have selected samples from
HapMap trios and the inferred SNPs followed Mendelian
patterns of inheritance within each trio. Furthermore the
inferred SNPs were observed and concordant between
replicate samples built into our experimental design
(individual samples, pooled samples and WGA samples)
for HapMap family 1420.
After genotypes were calculated for these positive
control SNPs (i.e. SNPs validated across multiple samples),
Table 1 Sample throughput and sequence capacity- general sequencing and enrichment metrics
HapMap sample ID Sample type Library ID Reads Mapped On-target % ADoC C1 C20 Coverage 0.2X mean
NA12003 gDNA 759L 36,453,208 33.50% 65.30% 2,121 99.50% 98.00% 86.10%
WGA 765L 42,752,716 36.30% 63.20% 2,588 99.60% 98.10% 86.40%
gDNA-pB 770L_BC1 10,031,809 36.40% 64.10% 621 99.00% 96.50% 86.50%
gDNA-pA 792L_BC1 5,221,822 31.60% 64.20% 280 98.40% 93.50% 85.70%
NA12004 gDNA 760L 39,005,646 31.00% 73.30% 2,356 99.40% 98.00% 86.30%
WGA 766L 43,079,257 17.50% 64.40% 1,273 99.40% 97.20% 84.80%
gDNA-pB 770L_BC2 3,272,424 39.30% 72.70% 249 98.30% 93.60% 87.10%
gDNA-pA 792L_BC2 6,023,113 32.50% 72.90% 380 98.50% 94.60% 85.70%
NA10838 gDNA 761L 35,573,703 21.10% 66.00% 1,309 99.40% 97.50% 85.90%
WGA 767L 43,140,968 30.60% 57.80% 2,014 99.60% 98.20% 86.50%
gDNA-pB 770L_BC3 7,114,637 35.80% 67.50% 456 98.60% 95.30% 85.80%
gDNA-pA 792L_BC3 6,587,601 34.00% 67.60% 401 98.60% 94.90% 85.80%
NA11829 gDNA 762L 39,864,620 29.20% 63.90% 1,961 99.60% 97.90% 85.50%
gDNA-pB 770L_BC4* 638,985 36.40% 66.00% 41 95.40% 63.40% 84.60%
gDNA-pA 792L_BC4* 677,767 28.50% 66.40% 34 94.50% 55.40% 84.90%
NA11830 gDNA 763L 38,654,830 34.10% 68.50% 2,404 99.70% 98.10% 85.80%
gDNA-pB 770L_BC5 Insufficient amount of material to run sample
gDNA-pA 792L_BC5 5,403,560 32.80% 68.10% 320 98.40% 94.10% 85.60%
NA10856 gDNA 764L 43,185,707 34.60% 61.10% 2,418 99.50% 98.00% 85.80%
gDNA-pB 770L_BC6 9,255,333 36.30% 61.30% 545 98.90% 96.00% 85.90%
gDNA-pA 792L_BC6 6,435,690 33.90% 62.00% 357 98.50% 94.40% 85.00%
Pooled Samples gDNA 768L_1 41,913,860 32.40% 67.00% 2,406 99.80% 98.30% 84.90%
gDNA 768L_2 41,958,628 33.40% 66.70% 2,474 99.60% 98.30% 85.30%
- Reads: Total sequencing reads per sample.
- Mapped: Percentage of total reads that could be aligned to the human genome (hg18/NCBI).
- On-Target: Percentage of mapped reads that align to the target regions.
- ADoC: Average depth of coverage of target base.
- C1: Percentage of target bases that are covered by at least one sequencing read.
- C20: Percentage of target bases that are covered by at least 20 sequencing reads.
- Coverage 0.2× Mean: Percentage of target bases that are covered by at least 0.2× of ADoC. Note that one barcode (BC4) was underrepresented (assigned with
“*” in this Table; see also Results and Discussion sections).
- gDNA: genomic DNA; WGA: whole-genome amplification; emPCR: emulsion PCR; BC: barcode.
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http://www.biomedcentral.com/1471-2164/13/500a cumulative genotype was calculated for the pool. SNP
detection in the non-barcoded, pooled samples were such
that the non-reference allele had to represent at least 1%
of the total allele count for a given nucleotide. The mini-
mum number of counts for each non-reference allele was
varied (5, 10, and 20) to optimize sensitivity and specificity
(Table 3). The lowest false SNP discovery rate (~10%) in
the technical replicates was detected at a stringent cover-
age parameter (20×). The reverse holds true at lower (5×)
coverage; we reached 40% false discovery rate (Table 3).
Actual allele frequencies in the two pooled samples
before library preparation (768_1L and 768_2L) correlated
well (Pearson R2 = 0.90 and 0.93, respectively) with pre-
dicted allele frequencies of the pooled gDNA samples
(Figure 2a and 2b). The non-reference allele frequencies
were very consistent between the two technical replicates,as illustrated in Figure 3 with high Pearson correlation
coefficient (R2 = 0.96).
Minor allele detection and Mendelian inheritance quality
check
The two pooled samples before library preparation
(gDNA samples: Library IDs 768_1L and 768_2L) were
also evaluated to detect minor alleles represented in the
pool based on the known reference genotypes for each
of the individual samples within each pool. The
predicted minor allele frequency (MAF) for each sample
was calculated by combining the genotypes of each of
the six individual samples within the pooled sample. The
actual minor allele frequency was calculated for each SNP
within the sequenced samples. Boxplots were generated for
the three smallest expected MAFs (Figure 4). In each case,
Table 2 Variant detection and concordance- SNP concordance with HapMap genotypes






NA12003 gDNA 759L 98.20% 100.00% 100.00% 100.00% 268 0 0,0%
WGA 765L 97.80% 100.00% 100.00% 100.00% 268 0 0,0%
gDNA-pB 770L_BC1 97.40% 100.00% 100.00% 100.00% 268 2 0,7%
gDNA-pA 792L_BC1 96.50% 100.00% 100.00% 100.00% 268 5 1,9%
NA12004 gDNA 760L 99.10% 99.10% 99.10% 100.00% 138 0 0,0%
WGA 766L 99.10% 99.10% 99.10% 100.00% 138 1 0,7%
gDNA-pB 770L_BC2 98.30% 99.10% 99.10% 100.00% 138 3 2,2%
gDNA-pA 792L_BC2 97.40% 99.10% 99.10% 100.00% 138 3 2,2%
NA10838 gDNA 761L 99.10% 99.10% 98.90% 100.00% 270 2 0,7%
gDNA-pB 770L_BC3 98.70% 99.60% 99.50% 100.00% 270 3 1,1%
gDNA-pA 792L_BC3 98.30% 99.60% 99.50% 100.00% 270 2 0,7%
NA11829 gDNA 762L 97.90% 100.00% 100.00% 100.00% 274 2 0,7%
gDNA-pB 770L_BC4 91.0%* 99.50% 99.50% 100.00% 274 43 15,7%
gDNA-pA 792L_BC4 86.3%* 100.00% 100.00% 100.00% 274 55 20,1%
NA11830 gDNA 763L 99.10% 99.10% 100.00% 93.90% 272 0 0,0%
gDNA-pB 770L_BC5 Insufficient amount of material to run sample
gDNA-pA 792L_BC5 98.70% 99.10% 100.00% 94.10% 272 9 3,3%
NA10856 gDNA 764L 99.60% 99.60% 100.00% 97.40% 273 1 0,4%
gDNA-pB 770L_BC6 98.70% 99.10% 99.50% 97.30% 273 3 1,1%
gDNA-pA 792L_BC6 99.10% 99.60% 100.00% 97.40% 273 4 1,5%
- Detection: Percentage of SNPs that are covered by at least five sequencing reads.
- Concordance: Percentage of detected SNPs that matched the HapMap (HapMap Public Release #27; merged II + III) genotype. Due to the underrepresentation of
barcode 4 (BC4) in the pools 770 and 792, the detection and concordance rates were lower (assigned in this Table with *).
- gDNA: genomic DNA; WGA: whole-genome amplification; emPCR: emulsion PCR; BC: barcode.
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agreement as shown in Figure 4.
In addition, by evaluating family structure, we did not
detect any errors in the Mendelian patterns of inheritance
of genotypes between the parents and the offspring within
each trio (an overview of all SNPs and genotypes detected
is shown in Additional file 4: Table S5).
Discussion
Optimizing T-NGS methods with unbiased performance
using non-amplified and amplified (WGA) gDNA samples
is necessary to enable statistically powered large-scale
studies. Even if the cost of routine sequencing of the
human exome and whole-genome becomes affordable in
the near future, multiplexed T-NGS will serve alongside as
a downstream validation and diagnostic tool to reach
sufficient coverage with less sequencing, enabling the
investigation of a higher number of samples in parallel.
More specifically, T-NGS provides more power to catalogue
most types of variations present in clinically relevant
subsets of the genome at a fraction of the cost of whole-
genome sequencing. Therefore, using mixed approaches,
for instance whole-genome sequencing at low-coveragefollowed by T-NGS at higher coverage, may become
more applicable in the coming years [23].
In the present study, we tested the performance of
combining a microdroplet-based PCR targeted sequencing
approach to NGS and demonstrated its utility in T-NGS
of 384 cancer exons throughout the genome of different
comparisons. We evaluated the performance of standard
gDNA (without amplification) versus whole-genome amp-
lified (WGA) gDNA samples as well as testing different
sample indexing strategies from the sequencing workflow,
namely pooled samples before library preparation (without
sample indexing) versus individual samples, and pre- versus
post-emPCR with sample indexing using SOLiD molecular
barcodes. The results of T-NGS of 384 cancer exons
demonstrate sequencing specificity of 66.0% ± 3.4%,
uniformity (coverage at 0.2× of the mean) of 85.6% ± 0.6%,
concordance of 99.5% ± 0.4% and no Mendelian inheritance
errors. We have also demonstrated the ability to detect
minor allele frequencies within pools of six non-barcoded
non-amplified gDNA samples. These results show the
possibility to process WGA gDNA samples at nearly similar
performance to that of standard non-amplified gDNA
samples without showing significant allelic bias/difference
Table 3 Efficiency and SNP detection rates of non-barcoded and pooled samples
Minimum read
count for SNP call








5 768_1L 244 226 376 92,6% 39,9%
768_2L 244 230 371 94,3% 38,0%
10 768_1L 244 212 277 86,9% 23,5%
768_2L 244 212 267 86,9% 20,6%
20 768_1L 244 193 214 79,1% 9,8%
768_2L 244 198 221 81,1% 10,4%
- Minimum read count for SNP call: Minimum number of non-reference allele counts required for a SNP to be considered detected.
- Positive control SNPs: Positive control SNPs generated from the non-pooled, non-barcoded data (759–764). Since the HapMap genotyping data was
incomplete, even for known SNPs, we attempted to create a positive control set of SNPs within the targeted regions. If the SNP was detected within samples 759–
764, a combined genotype was determined for that SNP position. For example, position X was determined to have a “CG” genotype in sample 759 and position X
had the reference genotype of “CC” in samples 760–764, the predicted allele frequency would be 8.3% (1 in 12). In the non-pooled samples, a SNP with a non-
reference allele frequency of 10-90% was considered a heterozygote. A homozygous SNP in non-pooled samples was defined as having >90% non-reference allele
frequency. The number in this column represents the total number of SNPs that have a non-reference allele within a given pooled sample. Note that these
positive control SNPs include HapMap samples with rs IDs, non-HapMap samples with rs IDs, and potentially novel SNPs.
- Positive control SNPs found: This number represents the number of positive control SNPs that were detected in a given pool with a given set of parameters.
- Total SNPs detected: This number represents the total number of SNPs found in a given pool with a given set of parameters. This number contains the
“positive SNPs found” plus other SNPs. It is assumed that most of these SNPs are false positives since this number decreases significantly if you increase the
stringency of your SNP detection parameters. However, some novel SNPs could exist in this set.
- Sensitivity: In this case, this is simply the percentage of positive controls SNPs found in a given pool with a given set of parameters. Sensitivity decreases as SNP
detection stringency increases.
- False Discovery Rate: This was defined as (total SNPs detected – positive control SNPs found)/Total SNPs detected * 100.
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non-pooled and pooled samples. For instance, 95% of the
targeted regions in the six HapMap samples that were
tested (two different HapMap trios) were covered with at
least 20× coverage while maintaining a 99.5% average
genotype concordance across all of the samples.
The results show that combining the applied target
enrichment approach with NGS technology provided
many advantages. This T-NGS approach leverages the
sensitivity and specificity of the PCR to efficiently capture
and represent the sequence context from different genomic
regions [10]. The stringency and flexibility to allocate
primers to the targets of interest are required to tackle
complex genomic regions of high homology (pseudogenes)
and repetitive elements [24-26]. The uniformity of the
sequence coverage across all the targeted regions in the
indexed samples allows for efficient use of NGS sequencing
capacity. Typical uniformity with a panel achieves greater
than 85% of bases within 0.2× of the mean coverage. This
level of performance allows for predictable sequence
coverage beyond what is reported in Table 1 with the
appropriate amount of sequencing per sample (see
additional coverage analysis in Additional file 3: Table S4).
The utilized NGS platform, with its high throughput,
allows accurate SNP detection as argued [27] and shown
here. Inadequate enrichment and/or coverage depth, which
is not the case in our study, can cause failure to detect real
nucleotide variation (Table 1; Additional file 4: Table S5),
which may lead to higher false-negative rates in particular
for heterozygotes [28,29]. In fact, comparable coverage
depth and uniformity of the tested 384 exons have been
achieved using other NGS technology platforms, 454 FLXand Illumina (Additional file 3: Table S6). As illustrated in
Table 2, parallel detection of both homozygous and hetero-
zygous genotypes, points to the efficiency of the tested
workflow and indicates that little, if any allelic bias has
been introduced during sample enrichment and sequen-
cing processes.
One exception to the observed even distribution of all
tested bar-coded samples was the lower representation
of samples indexed with BC4. We supposed at first that
this might be due to inaccurate quantification and
pooling; i.e. lower representation of BC4 in the original
libraries before pooling/enrichment, either due to a pipet-
ting error or a wrong DNA concentration measurement
during library preparation. Surprisingly, we have also
observed the substantial underrepresentation of indexed
samples with BC4 in other multiplex experiments using a
different sample enrichment technique, hybridization-based
sequence capture, in three successive runs [30]. So we con-
sidered BC4 as an outlier and we recommend avoiding it in
future experiments. In addition, the relatively high SNP
false discovery rate (10-40%; Table 3) of the non-barcoded
technical replicates (samples 768_1L and 768_2L), although
it seems to be dependent to some extent on coverage
depth, it indicates that pooling enriched gDNA samples be-
fore library construction, using the current T-NGS
approach, may not be a sensible option. We have mainly
tested this pooling option to access the reproducibility of
the established workflow (Figure 3). These results in general
emphasize the need to achieve higher coverage to reduce
the SNP false discovery rate. Applying of a similar pooling
option to enriched WGA samples will likely result in worse
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b
Figure 2 (a and b) Actual Versus Predicted Allele Frequencies in Pooled Samples. These two Figures show the correlation between
predicted (X-axis) and observed (Y-axis) non-reference allele frequencies in the two pooled gDNA samples before SOLiD library preparation,
namely sample/library 768_1L (replicate 1; Figure 2a) and 768_2L (replicate 2; Figure 2b). For each positive control SNP, a genotype was inferred
from the non-pooled sequencing samples. Composite SNP allele frequencies were calculated for each pool and compared to the actual SNP
allele frequencies. R2 values represent the square of the Pearson coefficient and reveal good correlation between samples (0.9045 and 0.9261 of
sample 768_1L and 768_2L, respectively).
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http://www.biomedcentral.com/1471-2164/13/500bias from different DNA amplification reactions. Instead,
we recommend pooling the samples before or after emPCR
in the course of the NGS protocol (see Table 2 for more
details).
Another clear limitation in our study, which needs to
be acknowledged, is the relatively low percentage of
mapped reads to the human genome (Table 1). Thepercentage of mapped reads depends on several factors,
such as NGS technology platform, target-enrichment
approach, mapping approach, and software and analytical
approaches. Using the same target region and RainDance
amplicon library on different NGS technology platforms
resulted in opposite numbers of produced reads and
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Figure 3 Reproducibility of target enrichment: Library 768_1L vs. Library 768_2L. Figure 3 shows the comparison of non-reference allele
frequency within the two technical replicates (768_1L and 768_2L). R2 represents the square of the Pearson coefficient and reveals high
consistency (R2 = 0.9632), and hence reproducibility, between the two replicates.
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http://www.biomedcentral.com/1471-2164/13/500Additional file 3: Table S6). While the long-read NGS plat-
form (454 FLX) generated a lower total number of reads
(219,876), the percentage of mapped reads was as high as
84%. In contrast, only up to 40% of the 5 to 44 million
reads produced by the short-read NGS platforms (SOLiD
and Illumina) mapped to the human genome. This might
indicate that shearing of the enriched PCR amplicons dur-
ing preparation of the sequencing libraries for the short-
read NGS platforms (Additional file 2: Figure S3 A and B)
leads to generation of fragments that are ambiguously
mapped to several locations of the genome (i.e. off-targets).
In fact, CLC bio and other mapping tools, such as BWA,
randomly map these ambiguous reads to one of the ‘pos-
sible’ locations. In addition, we found recently that the
quality of SNP calling was substantially affected by the
choice of mapping strategy and analytical tools [30]. For ex-
ample, we showed that the tested widely-used SNP-callers
do not seem to be well-trained to handle enrichment data,
and thus produced a significant fraction of false positive as
well as negative SNP calls. Moreover, changing the mapping
settings or using another software version can result in
different enrichment metrics. This observation was
confirmed here using a newer version of the CLC bio
Workbench software (version 5.1), which, for instance,
improved the mapping specificity to up to 56% (for details
see new Additional file 3: Table S4). The drop in mapping
percentage, while apparently worrisome, can still be
satisfactory as long as it does not impact on the accuracy of
the downstream SNP calling. In other words, achieving a
high and even coverage at intended bases (vertical coverage;
≥20×) and good on-target percentage (completeness orhorizontal coverage; 60 - 80%), as shown in our study,
ensure accurate SNP calling.
The “barcoding” approach holds promise to enable the
sequencing of large numbers of samples, and allows for
the identification of rare and novel variations in the
intended loci as well as variant carrier post-sequencing.
Comparing the results of multiplexed barcoded samples
pre- and post-emPCR revealed similar performances of
both schemes (Table 1, Table 2 and Additional file 2:
Figure S6). Therefore we recommend pooling samples
before emPCR to save money, time, and effort. Indeed,
the best design is to index samples and pool them before
enrichment. Testing pre-enrichment sample multiplex
was unfortunately infeasible using the applied target-
enrichment method and due to the limited length of the
generated sequence reads of the utilized SOLiD platform
(version 3.0). If we consider 50 bp sequencing reads as
an example, then we would expect that at least ≥5-10%
of the sequencing capacity will be lost to sequence only
the PCR primers (mean length of 20 bases). Sample
pooling before target enrichment is possible using array/
hybridization-based sequence capture methods and no
loss in sequence capacity is expected, since the binding
oligos/probes are kept fixed on the array and only the
enriched genomic products are eluted from the array
and sequenced [30]. The array-based sequence capture
approach may however be limited with regard to selection
of complete genomic regions due to repeat masking before
designing certain capture probes.
As a final point, due to the knowledge of the exact
start and stop position of each amplicon within the
Figure 4 Pooling of non-barcoded samples to detect rare variants. Figure 4 shows the ability to detect minor alleles represented in the two
technical replicates (pooled samples before library preparation; samples IDs 768_1L and 768_2L), based on the known reference genotypes for
each of the individual samples within each pool. In each case, the predicted frequency (blue boxplots) and the actual frequency (red boxplots) were in
agreement.
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http://www.biomedcentral.com/1471-2164/13/500primer library, the necessary amount of sequencing
required for a given sample can be precisely calculated,
depending on the level of coverage that is required. For
the 384 amplicon library used in this study, the sum
total of amplicon bases was 172,805. The amount of
sequencing required to achieve 100× average coverage,
which results in >85% of the bases represented at a
minimum coverage of 20×, is 17,280,500 bases. The total
reads for the 6× pool (792L BCs 1–6) was 33,169,196
total reads and 7,221,473 reads on target, resulting in
361,073,648 bases per octet. This would have allowed up
to 20 samples to be pooled per octet or 160 samples per
flow cell and 320 samples per run on the SOLiD v3 system
(Additional file 3: Table S7). Another practicable scenario
to improve coverage for larger target regions could be
using a lower degree of multiplexing (2-, 3-, 4-, or 5-plex
scheme) on a quarter of a sequencing slide (quads; 4 well
slide) instead of on an eighth of a slide (octant; 8 well
slide). Following such a strategy would allow more
sequencing room and subsequent higher coverage magni-
tude; by decreasing the inherent effect of slide’s physical
separation that decreases the overall number of sequences
obtained. In addition, recent rapid improvement of NGS
technologies would in principle allow a higher level of
sample multiplexing to bring per-sample cost down
further.
Conclusions
In this study, we have demonstrated the ability to
combine PCR solution-based targeted sequencing and
the high throughput of NGS to process samples that
have been pooled and indexed at several different steps
within the targeted sequencing workflow. For standard
gDNA we found no significant difference in the
sequence performance among the samples tested on theshort-read ABI SOLiD platform: The sequence specificity
(reads on target) was ~65%, the uniformity was ~85%, and
the genotype concordance was 99%. Although we here did
not test pooled WGA gDNA samples, the performance of
our non-pooled WGA samples showed sufficient promise
to merit more extensive investigations in the future. In
summary, the ability to generate high quality and uniform
sequence data across WGA and pooled gDNA samples
using the described T-NGS approach may allow research-
ers to achieve the necessary statistical power within their
studies to elucidate the underlying biology.Additional files
Additional file 1: Table S2. An Overview of the RDT 384 Member
Panel. Table includes individual tabs describing the amplicons, primers
and gff.
Additional file 2: Figure S1. RainDance Genomic DNA Template
Droplet and Primer Droplet Merge. PCR droplets are generated on the
RDT 1000 instrument (RainDance Technologies, Inc. USA). For a single
sample, the gDNA template mix and the RainDance 384 Member Primer
Library and four consumables are required, namely RDT 1000 Chip, RDT
1000 Template input/output vial, RDT 1000 Collect input/output vial, and
a PCR Tube Strip, Axygen Scientific. The RDT 1000 instrument generated
each PCR droplet by pairing a single gDNA template droplet with a
single primer droplet. The paired droplets flow past an electrode
embedded in the chip and are instantly merged creating the PCR
droplet. All of the resulting PCR droplets were automatically dispensed as
an emulsion into a single PCR tube and transferred to a standard thermal
cycler for PCR amplification. Figure S2. A and B Comparison of DNA
Fragment Distribution of RainDance 384 Member Primer Panel
BioAnalyzer Trace with RainDance 384 Member Primer Library Predicted
Amplicon Profile. Comparisons of the DNA fragment distribution of
RainDance 384 Member Primer Panel Bioanalyzer Trace (2A) with the
predicted profile (2B). As shown here, the amplicon profile obtained from
the Agilent Bioanalyzer results (2A) nicely matches the predicted
histogram distribution (2B). Figure S3. Removal of Primer-Dimer Peaks
Using Agencourt AMPure Kit. (A) A typical electropherogram obtained
showed a primer-dimer peak between 60 and 70 bp (~ 68 bp). B) The
primer-dimer peak (and other unincorporated dNTPs, primers, salts and
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http://www.biomedcentral.com/1471-2164/13/500other contaminants) were removed after purification of the SOLiD
Fragment Library (here Library 759L is shown as an example) using the
standard procedure of Agencourt AMPure Kit (Beckman Coulter
Genomics). Figure S4. Coverage Uniformity Across all the Barcoded and
Pooled Samples Before (pB) and After (pA) Emulsion PCR. A comparable
distribution of average depth of coverage (ADoC) across libraries pooled
before and after emulsion PCR (emPCR) is shown here. Barcoded libraries
pooled after emPCR (792 (pA)), showed more uniform ADoC. Samples
assigned to barcode 4 (yellow point) showed the lowest ADoC.
Additional file 3: Table S1. Overview of Sample Processing: RainDance
Sequence Enrichment, SOLiD Sequencing Library Construction and
Sample Indexing, Emulsion PCR and Sequencing. The samples were
enriched on the RDT1000, followed by shearing and standard library
construction according to the SOLiD 3.0 protocol (Applied Biosystems/
Life Technologies, USA). Six individual libraries were prepared using the
enriched gDNA products and indexed with barcodes 1 to 6 (Library IDs
759L, 760L, 761L, 762L, 763L and 764L). Three additional libraries were
prepared using the enriched WGA products and indexed with barcodes 9
to 11 (Library IDs 765L, 766L and 767L). To test the performance of each
step, the non-amplified samples were pooled before and after the library
preparation process. Pre-library preparation pools were created by
combining an equimolar portion of the 6 individual gDNA. The samples
were pooled together and processed as single samples (Library IDs
768_1L and 768_2L were duplicate libraries that contained six gDNA
samples). Post-library preparation pools were created by combining
equimolar portions of each individual sample post library preparation. A
post library preparation pool was generated before emPCR (Emulsion ID
770em: gDNA samples 1, 2, 3, 4 and 6) and after emPCR (Emulsion ID
792em: gDNA samples 1, 2, 3, 4, 5 and 6). The resulting PCR products
were sequenced on a SOLiD 3.0 system using 50 bp fragment libraries.
Table S3. CLC Bio SNP Detection Parameters. The following parameters
were used for SNP detection through the CLC bio Genomics Workbench
(version 3.0): Maximum coverage 50000. Maximum gap and mismatch
count 2. Minimum average quality 15. Minimum central quality 20.
Minimum coverage 5. Minimum variant frequency (%) 10.0. Variant count
threshold 50000. Window length 11. In the non-pooled samples, a SNP
with a non-reference allele frequency of 10-90% was considered a
heterozygote. A homozygous SNP in non-pooled samples was defined as
having >90% non-reference allele frequency. Table S4. Coverage Metrics
CLC bio Genomics Workbench (version 5.1). Table S6. Sequence Data
Generated Using 454 FLX and Illumina of the same Target Regions
(172kb/384 exons). Table S7. Sample Multiplexing Calculation for the
RDT 384 Member Panel and SOLiD Sequencing Platform.
Additional file 4: Table S5. An Overview of All SNPs and Genotypes
Detected. Genotypes from non-barcoded pooled samples. Table includes
both inferred and non-inferred genotypes.
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